Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 438,016 | 401,415 | 399,757 | 336,040 | 404,599 |
| Receivables | 86,919 | 68,094 | 37,258 | 12,491 | 3,684 |
| Inventories | 8,612 | 7,244 | 6,249 | 4,315 | N/A |
| Other current assets | 3,872 | 12,955 | 2,735 | 3,443 | 2,576 |
| TOTAL | $548,851 | $501,025 | $453,572 | $364,253 | $416,292 |
| Non-Current Assets | |||||
| PPE Net | 991 | 1,048 | 1,105 | 40 | 44 |
| Intangibles | 545 | 545 | 545 | 545 | 545 |
| Other Non-Current Assets | 22,484 | 23,318 | 19,020 | 16,980 | 17,242 |
| TOTAL | $24,020 | $24,911 | $20,670 | $17,565 | $17,831 |
| Total Assets | $572,871 | $525,936 | $474,242 | $381,818 | $434,123 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,522 | 13,564 | 12,366 | 7,000 | 4,152 |
| Accrued Expenses | 43,328 | 32,335 | 16,757 | 18,143 | 19,630 |
| Other current liabilities | 374 | 678 | 3,549 | 844 | 22,522 |
| TOTAL | $51,238 | $56,544 | $42,681 | $27,950 | $48,346 |
| Non-Current Liabilities | |||||
| Long Term Debt | 242,434 | 241,742 | 120,341 | 120,009 | 119,687 |
| Other Non-Current Liabilities | 926 | 1,055 | 106,661 | 102,019 | 96,338 |
| TOTAL | $243,360 | $242,797 | $227,002 | $223,377 | $217,503 |
| Total Liabilities | $294,598 | $299,341 | $269,683 | $251,327 | $265,849 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,192 | 85,132 | 84,979 | 81,831 | 81,235 |
| Common Shares | 45,021 | 45,021 | 45,021 | 42,771 | 42,771 |
| Retained earnings | -567,101 | -578,792 | -562,401 | -528,479 | -485,311 |
| Other shareholders' equity | -4,565 | -5,003 | -4,260 | -4,429 | -4,804 |
| TOTAL | $278,273 | $226,595 | $204,559 | $130,491 | $168,274 |
| Total Liabilities And Equity | $572,871 | $525,936 | $474,242 | $381,818 | $434,123 |